COMPANY PROFILE

Txbeyond

Explore full profile

Accelerating Drug Discovery by Computational Modeling

Huangpu, ChinaFounded 2021Biotech & Life Sciences

Valuation $100–500M Latest valuation · 2026

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Txbeyond

Beyond Therapeutics operates in the pharmaceutical and biotechnology sector, focusing on accelerating drug discovery using computational modeling. The company serves pharmaceutical companies, biotech firms, and research institutions. Its core product, the ExCEED Platform, integrates experiment, computation, and DMPK (Drug Metabolism and Pharmacokinetics) evaluation to streamline the drug discovery process. The platform leverages advanced technologies such as AI, PBPK (Physiologically Based Pharmacokinetic) modeling, and bioassay cloud solutions to enhance the efficacy, toxicity, and formulation of new drugs. Beyond Therapeutics generates revenue through subscription fees for its platform and consulting services. The company is headquartered in Shanghai and aims to revolutionize the drug discovery landscape by reducing time and costs associated with bringing new drugs to market.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2021
Headquarters: Huangpu, China
Employees: 4
Open positions: None listed
Dealroom signal: 57.5/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Technology: Deep Tech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Latest news

Press, funding announcements and product moves mentioning Txbeyond.

See all news

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Aug 2026	$30M	$120M	Shanghai Healthcare Capital · Legend Capital	↗
SEED✓Equity / VC	Jul 2023	$2.8M	$11M	Suzhou Sansu New Drug Development · Ming Bioventures · Shanghai Intertek Industrial	↗

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Txbeyond website traffic

Latest recorded traffic for Txbeyond is 30 monthly website visits, down 87% over the last three months. Txbeyond's team grew 0% over the past year.

Latest monthly visits30 3-month web change-87% 1-year team growth0%

Monthly website visitsJul 2023–Jun 2024

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
SMSuperluminal MedicinesGenerative biology and chemistry company revolutionizing the speed and accuracy of how medicine is created	Boston, United States	Operational	60	$213M	$240M
MEMetapinesNovel pharmaceutical composition for cancer treatment, where different compounds are simultaneously uptaken into cancer cells	Seongnam-si, South Korea	Operational
RMRVAC MedicinesMRNA platform company engaged in the research and development of innovative products such as vaccines for diseases	Singapore	Operational
APArthur PharmaHigh-tech innovative pharmaceutical manufacturer	Jiaxing, China	Operational
ETENSEM TherapeuticsBiotechnology company focusing on high value and difficult-to-drug oncology targets	Medford, United States	Operational
LTLTZ TherapeuticsDevelops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need	Redwood City, United States	Operational
CUCurifyLabsEnables sustainable, on-demand manufacture of medicines customized to provide safe and effective treatment for all patients	Helsinki, Finland	Operational
SESentanteDeveloping a radiation-reducing manipulator and a minimally invasive coronary robotic system for endovascular procedures	Kaunas, Lithuania	Operational